{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:03:06Z","timestamp":1790913786237,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,7,30]],"date-time":"2020-07-30T00:00:00Z","timestamp":1596067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,30]],"date-time":"2020-07-30T00:00:00Z","timestamp":1596067200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Circular RNAs (circRNAs) are emerging regulators in the development of human cancers. However, the role of circRNAs in melanoma is poorly understood. Microarray analysis and qRT-PCR was applied to screen out circRNAs that were differentially expressed in melanoma cells compared to normal cells. Currently, we first proved that inhibition of CYR61, an angiogenesis factor with controversial functions in melanoma, restrained cell migration, invasion and angiogenesis in melanoma. Thereafter, a novel circRNA hsa_circ_0027247 derived from GLI1 (circ-GLI1) was identified to positively modulate CYR61 expression in melanoma cell lines. Besides, silencing circ-GLI1 hindered melanoma cell metastasis as well. Interestingly, we unveiled that circ-GLI1 enhanced CYR61 transcription by an indirect manner. Meanwhile, circ-GLI1 activated Hedgehog\/GLI1 and Wnt\/\u03b2-catenin pathways by affecting the degradation of GLI1 and \u03b2-catenin. Moreover, we found that circ-GLI1 interacted with p70S6K2 to induce GSK3\u03b2 phosphorylation at Ser9, and therefore blocked the binding of GSK3\u03b2 with GLI1 and \u03b2-catenin so as to elevate their protein expression. Of note, CYR61 was transcriptionally activated by MYC, a well-recognized downstream target of both GLI1 and \u03b2-catenin. In conclusion, circ-GLI1 exacerbates the metastasis and angiogenesis of melanoma by upregulating Cyr61 via p70S6K2-dependent activation of Hedgehog\/GLI1 and Wnt\/\u03b2-catenin pathways.<\/jats:p>","DOI":"10.1038\/s41419-020-02799-x","type":"journal-article","created":{"date-parts":[[2020,7,30]],"date-time":"2020-07-30T06:24:08Z","timestamp":1596090248000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Circ-GLI1 promotes metastasis in melanoma through interacting with p70S6K2 to activate Hedgehog\/GLI1 and Wnt\/\u03b2-catenin pathways and upregulate Cyr61"],"prefix":"10.1038","volume":"11","author":[{"given":"Jun","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobo","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qilin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningli","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,30]]},"reference":[{"key":"2799_CR1","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1126\/science.1253735","volume":"346","author":"JA Lo","year":"2014","unstructured":"Lo, J. A. & Fisher, D. E. The melanoma revolution: from UV carcinogenesis to a new era in therapeutics. Science 346, 945\u2013949 (2014).","journal-title":"Science"},{"key":"2799_CR2","first-page":"9","volume":"64","author":"R Siegel","year":"2014","unstructured":"Siegel, R., Ma, J., Zou, Z. & Jemal, A. Cancer statistics, 2014. CA Cancer J. Clin. 64, 9\u201329 (2014).","journal-title":"CA Cancer J. Clin."},{"key":"2799_CR3","doi-asserted-by":"publisher","first-page":"S109","DOI":"10.1038\/515S109a","volume":"515","author":"B Owens","year":"2014","unstructured":"Owens, B. Melanoma. Nature 515, S109 (2014).","journal-title":"Nature"},{"key":"2799_CR4","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1038\/onc.2013.194","volume":"33","author":"WE Damsky","year":"2013","unstructured":"Damsky, W. E., Theodosakis, N. & Bosenberg, M. Melanoma metastasis: new concepts and evolving paradigms. Oncogene 33, 2413 (2013).","journal-title":"Oncogene"},{"key":"2799_CR5","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/med.21404","volume":"37","author":"A Millet","year":"2017","unstructured":"Millet, A. et al. Metastatic melanoma: insights into the evolution of the treatments and future challenges. Med. Res. Rev. 37, 98\u2013148 (2017).","journal-title":"Med. Res. Rev."},{"key":"2799_CR6","first-page":"171","volume":"64","author":"V Saranga-Perry","year":"2014","unstructured":"Saranga-Perry, V., Ambe, C., Zager, J. S. & Kudchadkar, R. R. Recent developments in the medical and surgical treatment of melanoma. CA Cancer J. Clin. 64, 171\u2013185 (2014).","journal-title":"CA Cancer J. Clin."},{"key":"2799_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.soc.2010.09.007","volume":"20","author":"PV Dickson","year":"2011","unstructured":"Dickson, P. V. & Gershenwald, J. E. Staging and prognosis of cutaneous melanoma. Surg. Oncol. Clin. N. Am. 20, 1\u201317 (2011).","journal-title":"Surg. Oncol. Clin. N. Am."},{"key":"2799_CR8","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ad.2014.02.013","volume":"106","author":"I Pastushenko","year":"2015","unstructured":"Pastushenko, I., Conejero, C. & Carapeto, F. J. Lymphangiogenesis: implications for diagnosis, treatment, and prognosis in patients with melanoma. Actas Dermosifiliogr. 106, 7\u201316 (2015).","journal-title":"Actas Dermosifiliogr."},{"key":"2799_CR9","doi-asserted-by":"publisher","first-page":"237","DOI":"10.3389\/fncel.2015.00237","volume":"9","author":"AR Malik","year":"2015","unstructured":"Malik, A. R., Liszewska, E. & Jaworski, J. Matricellular proteins of the Cyr61\/CTGF\/NOV (CCN) family and the nervous system. Front Cell Neurosci. 9, 237\u2013237 (2015).","journal-title":"Front Cell Neurosci."},{"key":"2799_CR10","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1200\/jco.2011.29.4_suppl.446","volume":"29","author":"M Baek","year":"2011","unstructured":"Baek, M., Bae, S. & Jeong, D. Relationship of pro-angiogenic factor Cyr61to colorectal cancer development and prognosis. J. Clin. Oncol. 29, 446 (2011).","journal-title":"J. Clin. Oncol."},{"key":"2799_CR11","doi-asserted-by":"publisher","first-page":"7243","DOI":"10.1158\/1078-0432.CCR-05-0231","volume":"11","author":"S Gery","year":"2005","unstructured":"Gery, S. et al. Ovarian carcinomas: CCN genes are aberrantly expressed and CCN1 promotes proliferation of these cells. Clin. Cancer Res. 11, 7243\u20137254 (2005).","journal-title":"Clin. Cancer Res."},{"key":"2799_CR12","doi-asserted-by":"publisher","first-page":"4847","DOI":"10.1038\/sj.onc.1207628","volume":"23","author":"X Tong","year":"2004","unstructured":"Tong, X. et al. Cyr61 suppresses the growth of non-small-cell lung cancer cells via the \u03b2-catenin\u2013c-myc\u2013p53 pathway. Oncogene 23, 4847\u20134855 (2004).","journal-title":"Oncogene"},{"key":"2799_CR13","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1038\/onc.2015.190","volume":"35","author":"CC Chen","year":"2016","unstructured":"Chen, C. C., Kim, K. H. & Lau, L. F. The matricellular protein CCN1 suppresses hepatocarcinogenesis by inhibiting compensatory proliferation. Oncogene 35, 1314\u20131323 (2016).","journal-title":"Oncogene"},{"key":"2799_CR14","doi-asserted-by":"publisher","first-page":"26194","DOI":"10.1074\/jbc.M109.019836","volume":"284","author":"AS Dobroff","year":"2009","unstructured":"Dobroff, A. S. et al. Silencing cAMP-response element-binding protein (CREB) identifies CYR61 as a tumor suppressor gene in melanoma. J. Biol. Chem. 284, 26194\u201326206 (2009).","journal-title":"J. Biol. Chem."},{"key":"2799_CR15","doi-asserted-by":"publisher","first-page":"2697","DOI":"10.3892\/or.2016.5124","volume":"36","author":"J Chen","year":"2016","unstructured":"Chen, J. et al. CYR61 suppresses growth of human malignant melanoma. Oncol. Rep. 36, 2697\u20132704 (2016).","journal-title":"Oncol. Rep."},{"key":"2799_CR16","doi-asserted-by":"publisher","first-page":"45651","DOI":"10.1074\/jbc.M301373200","volume":"278","author":"M Kunz","year":"2003","unstructured":"Kunz, M. et al. Mechanisms of hypoxic gene regulation of angiogenesis factor Cyr61 in melanoma cells. J. Biol. Chem. 278, 45651\u201345660 (2003).","journal-title":"J. Biol. Chem."},{"key":"2799_CR17","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1111\/j.1755-148X.2012.01004.x","volume":"25","author":"J Wouters","year":"2012","unstructured":"Wouters, J. et al. Gene expression changes in melanoma metastases in response to high-dose chemotherapy during isolated limb perfusion. Pigment Cell Melanoma Res. 25, 454\u2013465 (2012).","journal-title":"Pigment Cell Melanoma Res."},{"key":"2799_CR18","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1160\/TH13-02-0158","volume":"110","author":"P Schmitz","year":"2013","unstructured":"Schmitz, P. et al. Cyr61 is a target for heparin in reducing MV3 melanoma cell adhesion and migration via the integrin VLA-4. Thromb. Haemost. 110, 1046\u20131054 (2013).","journal-title":"Thromb. Haemost."},{"key":"2799_CR19","first-page":"19","volume":"226","author":"JJ Chan","year":"2018","unstructured":"Chan, J. J. & Tay, Y. Noncoding RNA:RNA regulatory networks in cancer. Int J. Mol. Sci. IF3 226, 19 (2018).","journal-title":"Int J. Mol. Sci. IF3"},{"key":"2799_CR20","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1152\/physrev.00041.2015","volume":"96","author":"J Beermann","year":"2016","unstructured":"Beermann, J., Piccoli, M. T., Viereck, J. & Thum, T. Non-coding RNAs in development and disease: background, mechanisms, and therapeutic approaches. Physiol. Rev. 96, 1297\u20131325 (2016).","journal-title":"Physiol. Rev."},{"key":"2799_CR21","doi-asserted-by":"publisher","unstructured":"Arnaiz, E. et al. CircRNAs and cancer: biomarkers and master regulators. Semin. Cancer Biol. https:\/\/doi.org\/10.1016\/j.semcancer.2018.12.002 (2018).","DOI":"10.1016\/j.semcancer.2018.12.002"},{"key":"2799_CR22","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.biopha.2018.08.152","volume":"108","author":"D Bian","year":"2018","unstructured":"Bian, D., Wu, Y. & Song, G. Novel circular RNA, hsa_circ_0025039 promotes cell growth, invasion and glucose metabolism in malignant melanoma via the miR-198\/CDK4 axis. Biomed. Pharmacother. 108, 165\u2013176 (2018).","journal-title":"Biomed. Pharmacother."},{"key":"2799_CR23","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.bbrc.2018.05.114","volume":"502","author":"W Luan","year":"2018","unstructured":"Luan, W. et al. circRNA_0084043 promote malignant melanoma progression via miR-153-3p\/Snail axis. Biochem. Biophys. Res. Commun. 502, 22\u201329 (2018).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2799_CR24","first-page":"5584","volume":"15","author":"J Huang","year":"2018","unstructured":"Huang, J. et al. Identification of lncRNAs by microarray analysis reveals the potential role of lncRNAs in cervical cancer pathogenesis. Oncol. Lett. 15, 5584\u20135592 (2018).","journal-title":"Oncol. Lett."},{"key":"2799_CR25","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.ccr.2008.09.007","volume":"14","author":"A Ruiz i Altaba","year":"2008","unstructured":"Ruiz i Altaba, A. Therapeutic inhibition of Hedgehog-GLI signaling in cancer: epithelial, stromal, or stem cell targets? Cancer Cell 14, 281\u2013283 (2008).","journal-title":"Cancer Cell"},{"key":"2799_CR26","doi-asserted-by":"publisher","first-page":"4489","DOI":"10.1038\/sj.onc.1210241","volume":"26","author":"X Li","year":"2007","unstructured":"Li, X., Deng, W., Lobo-Ruppert, S. M. & Ruppert, J. M. Gli1 acts through Snail and E-cadherin to promote nuclear signaling by beta-catenin. Oncogene 26, 4489\u20134498 (2007).","journal-title":"Oncogene"},{"key":"2799_CR27","doi-asserted-by":"publisher","unstructured":"Zhang, F. et al. Canonical hedgehog signaling regulates hepatic stellate cell-mediated angiogenesis in liver fibrosis. Br. J. Pharmacol. https:\/\/doi.org\/10.1111\/bph.13701 (2017).","DOI":"10.1111\/bph.13701"},{"key":"2799_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-8-123","volume":"8","author":"V Dormoy","year":"2009","unstructured":"Dormoy, V. et al. The sonic hedgehog signaling pathway is reactivated in human renal cell carcinoma and plays orchestral role in tumor growth. Mol. Cancer 8, 123 (2009).","journal-title":"Mol. Cancer"},{"key":"2799_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-30692-3","volume":"8","author":"LH Wang","year":"2018","unstructured":"Wang, L. H. et al. The antihelminthic niclosamide inhibits cancer stemness, extracellular matrix remodeling, and metastasis through dysregulation of the nuclear \u03b2-catenin\/c-Myc axis in OSCC. Sci. Rep. 8, 12776 (2018).","journal-title":"Sci. Rep."},{"key":"2799_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-014-0408-8","volume":"16","author":"Z Zhao","year":"2014","unstructured":"Zhao, Z. et al. Nestin positively regulates the Wnt\/\u03b2-catenin pathway and the proliferation, survival and invasiveness of breast cancer stem cells. Breast Cancer Res. 16, 408 (2014).","journal-title":"Breast Cancer Res."},{"key":"2799_CR31","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/1476-4598-8-44","volume":"8","author":"S Mizuarai","year":"2009","unstructured":"Mizuarai, S., Kawagishi, A. & Kotani, H. Inhibition of p70S6K2 down-regulates Hedgehog\/GLI pathway in non-small cell lung cancer cell lines. Mol. Cancer 8, 44\u201344 (2009).","journal-title":"Mol. Cancer"},{"key":"2799_CR32","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.tips.2004.07.006","volume":"25","author":"L Meijer","year":"2004","unstructured":"Meijer, L., Flajolet, M. & Greengard, P. Pharmacological inhibitors of glycogen synthase kinase 3. Trends Pharmacol. Sci. 25, 471\u2013480 (2004).","journal-title":"Trends Pharmacol. Sci."},{"key":"2799_CR33","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1182\/blood-2014-02-555813","volume":"124","author":"SK Johnson","year":"2014","unstructured":"Johnson, S. K. et al. CYR61\/CCN1 overexpression in the myeloma microenvironment is associated with superior survival and reduced bone disease. Blood 124, 2051\u20132060 (2014).","journal-title":"Blood"},{"key":"2799_CR34","doi-asserted-by":"publisher","first-page":"5908","DOI":"10.1158\/1078-0432.CCR-10-1200","volume":"16","author":"KB D\u2019Antonio","year":"2010","unstructured":"D\u2019Antonio, K. B. et al. Decreased expression of Cyr61 is associated with prostate cancer recurrence after surgical treatment. Clin. Cancer Res. 16, 5908\u20135913 (2010).","journal-title":"Clin. Cancer Res."},{"key":"2799_CR35","doi-asserted-by":"publisher","unstructured":"Zhou, X. et al. Long noncoding RNA CPS1-IT1 suppresses melanoma cell metastasis through inhibiting Cyr61 via competitively binding to BRG1. J. Cell. Physiol. https:\/\/doi.org\/10.1002\/jcp.28764 (2019).","DOI":"10.1002\/jcp.28764"},{"key":"2799_CR36","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12943-017-0663-2","volume":"16","author":"S Meng","year":"2017","unstructured":"Meng, S. et al. CircRNA: functions and properties of a novel potential biomarker for cancer. Mol. cancer 16, 94\u201394 (2017).","journal-title":"Mol. cancer"},{"key":"2799_CR37","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1002\/path.5125","volume":"246","author":"X Li","year":"2018","unstructured":"Li, X. et al. Circular RNA circITGA7 inhibits colorectal cancer growth and metastasis by modulating the Ras pathway and upregulating transcription of its host gene ITGA7. J. Pathol. 246, 166\u2013179 (2018).","journal-title":"J. Pathol."},{"key":"2799_CR38","doi-asserted-by":"publisher","first-page":"3580","DOI":"10.1093\/nar\/gkz141","volume":"47","author":"P Kong","year":"2019","unstructured":"Kong, P. et al. circ-Sirt1 controls NF-\u03baB activation via sequence-specific interaction and enhancement of SIRT1 expression by binding to miR-132\/212 in vascular smooth muscle cells. Nucleic Acids Res. 47, 3580\u20133593 (2019).","journal-title":"Nucleic Acids Res."},{"key":"2799_CR39","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s13046-017-0614-1","volume":"36","author":"R He","year":"2017","unstructured":"He, R. et al. circGFRA1 and GFRA1 act as ceRNAs in triple negative breast cancer by regulating miR-34a. J. Exp. Clin. Cancer Res 36, 145\u2013145 (2017).","journal-title":"J. Exp. Clin. Cancer Res"},{"key":"2799_CR40","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/nature09851","volume":"472","author":"K Shin","year":"2011","unstructured":"Shin, K. et al. Hedgehog\/Wnt feedback supports regenerative proliferation of epithelial stem cells in bladder. Nature 472, 110\u2013114 (2011).","journal-title":"Nature"},{"key":"2799_CR41","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1053\/j.gastro.2009.04.059","volume":"137","author":"S Arimura","year":"2009","unstructured":"Arimura, S. et al. Reduced level of smoothened suppresses intestinal tumorigenesis by down-regulation of Wnt signaling. Gastroenterology 137, 629\u2013638 (2009).","journal-title":"Gastroenterology"},{"key":"2799_CR42","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1002\/wrna.1294","volume":"6","author":"I Chen","year":"2015","unstructured":"Chen, I., Chen, C.-Y. & Chuang, T.-J. Biogenesis, identification, and function of exonic circular RNAs. Wiley Interdiscip. Rev. RNA 6, 563\u2013579 (2015).","journal-title":"Wiley Interdiscip. Rev. RNA"},{"key":"2799_CR43","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/S0092-8674(02)00664-5","volume":"108","author":"MA Price","year":"2002","unstructured":"Price, M. A. & Kalderon, D. Proteolysis of the Hedgehog signaling effector cubitus interruptus requires phosphorylation by glycogen synthase kinase 3 and casein kinase 1. Cell 108, 823\u2013835 (2002).","journal-title":"Cell"},{"key":"2799_CR44","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1126\/science.272.5264.1023","volume":"272","author":"B Rubinfeld","year":"1996","unstructured":"Rubinfeld, B. et al. Binding of GSK3\u03b2 to the APC-\u03b2-catenin complex and regulation of complex assembly. Science 272, 1023 (1996).","journal-title":"Science"},{"key":"2799_CR45","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1136\/gutjnl-2014-307191","volume":"64","author":"M Soutto","year":"2015","unstructured":"Soutto, M. et al. Activation of \u03b2-catenin signalling by TFF1 loss promotes cell proliferation and gastric tumorigenesis. Gut 64, 1028\u20131039 (2015).","journal-title":"Gut"},{"key":"2799_CR46","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1038\/nrc1229","volume":"3","author":"MP di Magliano","year":"2003","unstructured":"di Magliano, M. P. & Hebrok, M. Hedgehog signalling in cancer formation and maintenance. Nat. Rev. Cancer 3, 903\u2013911 (2003).","journal-title":"Nat. Rev. Cancer"},{"key":"2799_CR47","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1158\/1541-7786.MCR-13-0170","volume":"11","author":"B Gurung","year":"2013","unstructured":"Gurung, B., Feng, Z. & Hua, X. Menin directly represses Gli1 expression independent of canonical Hedgehog signaling. Mol. Cancer Res. 11, 1215\u20131222 (2013).","journal-title":"Mol. Cancer Res."},{"key":"2799_CR48","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1158\/0008-5472.CAN-15-2906","volume":"77","author":"M Jung","year":"2017","unstructured":"Jung, M. et al. A Myc activity signature predicts poor clinical outcomes in Myc-associated cancers. Cancer Res. 77, 971\u2013981 (2017).","journal-title":"Cancer Res."},{"key":"2799_CR49","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1158\/1541-7786.MCR-12-0441","volume":"11","author":"JW Yoon","year":"2013","unstructured":"Yoon, J. W. et al. Noncanonical regulation of the Hedgehog mediator GLI1 by c-MYC in Burkitt lymphoma. Mol. Cancer Res. 11, 604\u2013615 (2013).","journal-title":"Mol. Cancer Res."},{"key":"2799_CR50","doi-asserted-by":"publisher","first-page":"3282","DOI":"10.1038\/sj.onc.1210991","volume":"27","author":"JP Zwerner","year":"2007","unstructured":"Zwerner, J. P. et al. The EWS\/FLI1 oncogenic transcription factor deregulates GLI1. Oncogene 27, 3282 (2007).","journal-title":"Oncogene"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-02799-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-02799-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-02799-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T10:02:59Z","timestamp":1760090579000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-02799-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,30]]},"references-count":50,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020,7]]}},"alternative-id":["2799"],"URL":"https:\/\/doi.org\/10.1038\/s41419-020-02799-x","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,30]]},"assertion":[{"value":"7 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"596"}}